Peutz-Jeghers syndrome |
Classification and external resources |
Micrograph of Peutz-Jeghers type colonic polyp. H&E stain. |
ICD-10 |
Q85.8 |
ICD-9 |
759.6 |
OMIM |
175200 |
DiseasesDB |
9905 |
MedlinePlus |
000244 |
eMedicine |
med/1807 article/182006article/1664349 |
MeSH |
D010580 |
GeneReviews |
|
Peutz–Jeghers syndrome, also known as hereditary intestinal polyposis syndrome, is an autosomal dominant genetic disease characterized by the development of benign hamartomatous polyps in the gastrointestinal tract and hyperpigmented macules on the lips and oral mucosa.[1]:857 Peutz–Jeghers syndrome has an incidence of approximately 1 in 25,000 to 300,000 births [2]
Contents
- 1 Diagnosis
- 2 Natural history
- 3 Genetics
- 4 Limited evidence base
- 5 Presentation
- 6 Cancer screening
- 7 See also
- 8 References
- 9 External links
|
Diagnosis
The main criteria for clinical diagnosis are:
- Family history
- Mucocutaneous lesions causing patches of hyperpigmentation in the mouth and on the hands and feet. The oral pigmentations are the first on the body to appear, and thus play an important part in early diagnosis. Intraorally, they are most frequently seen on the gingiva, hard palate and inside of the cheek. The mucosa of the lower lip is almost invariably involved as well.
- Hamartomatous polyps in the gastrointestinal tract. These are benign polyps with an extraordinarily low potential for malignancy.
Having 2 of the 3 listed clinical criteria indicates a positive diagnosis. The oral findings are consistent with other conditions, such as Addison's disease and McCune-Albright syndrome, and these should be included in the differential diagnosis. 90-100% of patients with a clinical diagnosis of PJS have a mutation in the STK11/LKB1 gene. Molecular genetic testing for this mutation is available clinically.[3]
Natural history
Most people with Peutz-Jeghers syndrome will have developed some form of neoplastic disease by age 60
Most patients will develop flat, brownish spots (melanotic macules) on the skin, especially on the lips and oral mucosa, during the first year of life, and a patient’s first bowel obstruction due to intussusception usually occurs between the ages of six and 18 years. The cumulative lifetime cancer risk begins to rise in middle age. Cumulative risks by age 70 for all cancers, gastrointestinal (GI) cancers, and pancreatic cancer are 85%, 57%, and 11%, respectively.
Genetics
In 1998, a gene was found to be associated with the mutation. On chromosome 19, the gene known as STK11 (LKB1)[4] is a possible tumor suppressor gene. It is inherited in an autosomal-dominant pattern (see Mendelian inheritance) which means that anyone who has PJS has a 50% chance of passing it onto their children, assuming that their spouse does not have the disease.
Limited evidence base
Peutz–Jeghers syndrome is rare and studies typically include only a small number of patients. Even in those few studies that do contain a large number of patients, the quality of the evidence is limited due to pooling patients from many centers, selection bias (only patients with health problems coming from treatment are included), and historical bias (the patients reported are from a time before advances in the diagnosis of treatment of Peutz–Jeghers syndrome were made). Probably due to this limited evidence base, cancer risk estimates for Peutz–Jeghers syndrome vary from study to study.[5]
Presentation
The risks associated with this syndrome include a strong tendency of developing cancer in multiple sites.[6] While the hamartomatous polyps themselves only have a small malignant potential (<3% - OHCM), patients with the syndrome have an increased risk of developing carcinomas of the pancreas, liver, lungs, breast, ovaries, uterus, testicles and other organs.
The average age of first diagnosis is 23, but the lesions can be identified at birth by an astute pediatrician. Prior to puberty, the mucocutaneous lesions can be found on the palms and soles. Often the first presentation is as a bowel obstruction from an intussusception which is a common cause of mortality; an intussusception is a telescoping of one loop of bowel into another segment.
Cancer screening
Barium enema radiograph showing multiple polyps (mostly pedunculated) and at least one large mass at the hepatic flexure coated with contrast in a patient with Peutz–Jeghers syndrome.
Some suggestions for surveillance for cancer include the following:
- Small intestine with small bowel radiography every 2 years,
- Esophagogastroduodenoscopy and colonoscopy every 2 years,
- CT scan or MRI of the pancreas yearly,
- Ultrasound of the pelvis (women) and testes (men) yearly,
- Mammography (women) from age 25 annually livelong,[7] and
- Papanicolaou (Pap) test every year
Follow-up care should be supervised by a physician familiar with Peutz–Jeghers syndrome. Genetic consultation and counseling as well as urological and gynecological consultations are often needed.
See also
- List of cutaneous conditions
- Sex cord tumour with annular tubules
References
- ^ James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0-7216-2921-0.
- ^ Jerry E. Bouquot; Neville, Brad W.; Damm, Douglas D.; Allen, Carl P. (2008). Oral and Maxillofacial Pathology. Philadelphia: Saunders. pp. 16.11. ISBN 1-4160-3435-8.
- ^ Peutz-Jeghers Syndrome. Amos CI, Frazier ML, McGarrity TJ. In: Pagon RA, Bird TC, Dolan CR, Stephens K, editors. GeneReviews [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2001 Feb 23 [updated 2007 May 15]
- ^ "UniProtKB/Swiss-Prot entry Q15831 [STK11_HUMAN Serine/threonine-protein kinase 11"]. http://us.expasy.org/cgi-bin/niceprot.pl?Q15831. Retrieved 2007-07-21.
- ^ "Peutz-Jeghers Syndrome : In Familial Cancer Syndromes. DL Riegert-Johnson and others. NCBI 2009". http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=famcan&part=ch1famcan. Retrieved 2009-07-21.
- ^ Boardman LA, Thibodeau SN, Schaid DJ, et al. (1998). "Increased risk for cancer in patients with the Peutz-Jeghers syndrome". Ann. Intern. Med. 128 (11): 896–9. PMID 9634427.
- ^ GeneReviews .Pagon RA, Bird TD, Dolan CR, et al., editors Seattle (WA): University of Washington, Seattle; 1993-.PMID 20301443
External links
- GeneReviews/NCBI/NIH/UW entry on Peutz-Jeghers syndrome
- Peutz-Jeghers syndrome - Genetics Home Reference
Phakomatosis (Q85, 759.5–759.6)
|
|
Neurofibromatosis |
|
|
Angiomatosis |
- Sturge–Weber syndrome
- Von Hippel–Lindau disease
|
|
Hamartoma |
- Tuberous sclerosis
- Hypothalamic hamartoma (Pallister–Hall syndrome)
- Multiple hamartoma syndrome
- Proteus syndrome
- Cowden syndrome
- Bannayan–Riley–Ruvalcaba syndrome
- Lhermitte–Duclos disease
|
|
Other |
- Abdallat–Davis–Farrage syndrome
- Ataxia telangiectasia
- Incontinentia pigmenti
- Peutz–Jeghers syndrome
|
|
Tumors: digestive system neoplasia (C15–C26/D12–D13, 150–159/211)
|
|
GI tract |
Upper GI tract |
Esophagus |
- Squamous cell carcinoma
- Adenocarcinoma
|
|
Stomach |
- Gastric carcinoma
- Signet ring cell carcinoma
- Gastric lymphoma
- Linitis plastica
|
|
|
Lower GI tract |
Small intestine |
|
|
Appendix |
- Carcinoid
- Pseudomyxoma peritonei
|
|
Colon/rectum |
- colorectal polyp: Peutz–Jeghers syndrome
- Juvenile polyposis syndrome
- Familial adenomatous polyposis/Gardner's syndrome
- Cronkhite–Canada syndrome
- neoplasm: Adenocarcinoma
- Familial adenomatous polyposis
- Hereditary nonpolyposis colorectal cancer
|
|
Anus |
|
|
|
Upper and/or lower |
- Gastrointestinal stromal tumor
- Krukenberg tumor (metastatic)
|
|
|
Accessory |
Liver |
- malignant: Hepatocellular carcinoma
- Hepatoblastoma
- benign: Hepatocellular adenoma
- Cavernous hemangioma
- hyperplasia: Focal nodular hyperplasia
- Nodular regenerative hyperplasia
|
|
Biliary tract |
- bile duct: Cholangiocarcinoma
- Klatskin tumor
- gallbladder: Gallbladder cancer
|
|
Pancreas |
- exocrine pancreas: Adenocarcinoma
- Pancreatic ductal carcinoma
- cystic neoplasms: Serous microcystic adenoma
- Intraductal papillary mucinous neoplasm
- Mucinous cystic neoplasm
- Solid pseudopapillary neoplasm
|
|
|
Peritoneum |
- Primary peritoneal carcinoma
- Peritoneal mesothelioma
- Desmoplastic small round cell tumor
|
|
|
anat(t, g, p)/phys/devp/enzy
|
noco/cong/tumr, sysi/epon
|
proc, drug(A2A/2B/3/4/5/6/7/14/16), blte
|
|
|
|
Deficiencies of intracellular signaling peptides and proteins
|
|
GTP-binding protein regulators |
GTPase-activating protein |
- Neurofibromatosis type I
- Watson syndrome
- Tuberous sclerosis
|
|
Guanine nucleotide exchange factor |
- Marinesco–Sjögren syndrome
- Aarskog–Scott syndrome
- Juvenile primary lateral sclerosis
- X-Linked mental retardation 1
|
|
|
G protein |
Heterotrimeic |
- cAMP/GNAS1: Pseudopseudohypoparathyroidism
- Progressive osseous heteroplasia
- Pseudohypoparathyroidism
- Albright's hereditary osteodystrophy
- McCune–Albright syndrome
CGL 2
|
|
Monomeric |
- RAS: HRAS
- KRAS
- Noonan syndrome 3
- KRAS Cardiofaciocutaneous syndrome
- RAB: RAB7
- Charcot–Marie–Tooth disease
- RAB23
- RAB27
- Griscelli syndrome type 2
- RHO: RAC2
- Neutrophil immunodeficiency syndrome
- ARF: SAR1B
- Chylomicron retention disease
- ARL13B
- ARL6
|
|
|
MAP kinase |
- Cardiofaciocutaneous syndrome
|
|
Other kinase/phosphatase |
Tyrosine kinase |
- BTK
- X-linked agammaglobulinemia
- ZAP70
|
|
Serine/threonine kinase |
- RPS6KA3
- CHEK2
- IKBKG
- STK11
- DMPK
- ATR
- GRK1
- WNK4/WNK1
- Pseudohypoaldosteronism 2
|
|
Tyrosine phosphatase |
- PTEN
- Bannayan–Riley–Ruvalcaba syndrome
- Lhermitte–Duclos disease
- Cowden syndrome
- Proteus-like syndrome
- MTM1
- X-linked myotubular myopathy)
- PTPN11
- Noonan syndrome 1
- LEOPARD syndrome
- Metachondromatosis
|
|
|
Signal transducing adaptor proteins |
- EDARADD
- EDARADD Hypohidrotic ectodermal dysplasia
- SH3BP2
- LDB3
|
|
Other |
- NF2
- Neurofibromatosis type II
- NOTCH3
- PRKAR1A
- PRKAG2
- Wolff–Parkinson–White syndrome
- PRKCSH
- PRKCSH Polycystic liver disease
- XIAP
|
|
see also intracellular signaling peptides and proteins
- B structural
- perx
- skel
- cili
- mito
- nucl
- sclr
- DNA/RNA/protein synthesis
- membrane
- transduction
- trfk
|
|